Electric Vehicle Makers Rivian and Lucid Witness Stock Plunge Amid Q4 Earnings

Electric Vehicle Makers Rivian and Lucid Witness Stock Plunge Amid Q4 Earnings | Enterprise Wired

Share Post:

LinkedIn
Twitter
Facebook
Reddit

Source – techshots

Challenges in Production and Economic Uncertainties IImpact Shares

Shares of electric vehicle manufacturers Rivian and Lucid experienced a sharp decline on Thursday following the release of disappointing fourth-quarter earnings. Rivian shares plummeted approximately 25%, while Lucid’s stock saw a nearly 17% decline in value.

Production Forecasts for 2024

Rivian’s outlook for 2024 anticipates the production of 57,000 vehicles, a slight decrease from the 57,232 vehicles manufactured in the previous year. Lucid, on the other hand, projects the production of 9,000 vehicles in 2024, representing a modest 7% increase compared to the 8,428 vehicles produced in 2023.

Financial Performance and Workforce Reductions

While Rivian’s fourth-quarter revenue of $1.32 billion exceeded Wall Street estimates, the company reported a worse-than-expected net loss per share of $1.36. In response to economic and geopolitical uncertainties, including historically high-interest rates impacting demand, Rivian CEO RJ Scaringe announced a 10% reduction in the workforce during Wednesday’s earnings call.

Lucid reported lower-than-expected revenue of $157.2 million for the quarter. Lucid CEO Peter Rawlinson attributed the impact to the macroeconomic environment and higher interest rates. The company, expanding its operations to new locations such as Saudi Arabia, acknowledged adapting to different market dynamics.

EV Market Challenges and Slow Sales Growth

Despite significant investments in electric vehicles (EVs), industry-wide sales have grown slower than anticipated. As of December, EVs constituted 6.9% of total sales, totaling approximately 976,560 units, reflecting a 1.7 percentage point increase from 2022. Rivian and Lucid, while making strides, still account for a fraction of the EV market compared to industry leader Tesla.

According to a Cox Automotive analysis, Rivian represented just over 4% of EV sales in 2023, while Lucid comprised 0.5%. Tesla continued to dominate the market with a commanding 55% share.

Stock Performance and IPO Impact

Rivian’s shares have undergone a significant decline, dropping around 40% in the past year and plummeting 85% from their initial public offering price of $78 a share in November 2021. Similarly, Lucid’s stock witnessed a decline of approximately 70% in the past year and has fallen over 75% from its IPO price of $14 a share in October 2021.

Rivian and Lucid were not the sole focus of Wall Street on Thursday, as electric truck maker Nikola also reported worse-than-expected revenue and a slightly better-than-expected loss per share in its earnings, resulting in a relatively flat stock performance.

The challenges faced by these electric vehicle manufacturers highlight the complexities and uncertainties within the evolving EV market, influenced by production hurdles, economic factors, and growing competition.

Also Read: Divergent Paths: Rivian and Lucid Earnings Reflect Varying Fortunes in the EV World

Subscribe

RELATED ARTICLES

China’s Economic Growth Slows in August, Missing Expectations

China’s Economic Growth Slows in August, Missing Expectations

[Source – business-standard.com] Sluggish Retail Sales and Industrial Production China’s retail sales, industrial production, and urban investment for August grew…
Social Security Cost-of-Living Adjustment Likely to Drop in 2025

Social Security Cost-of-Living Adjustment Likely to Drop in 2025

(Source-marketwatch) After several years of high cost-of-living adjustments for Social Security (COLA) beneficiaries due to inflation, the increase for 2025…
Novo Nordisk’s Weight-Loss Pill Amycretin Shows Promising Results in Early Trial

Novo Nordisk’s Weight-Loss Pill Amycretin Shows Promising Results in Early Trial

(Source-nbcnews.com) Novo Nordisk, the maker of popular weight-loss drugs Wegovy and Ozempic, has announced that its experimental weight-loss pill, amycretin,…
OpenAI in Talks for $6.5 Billion Funding, Valuation Soars to $150 Billion

OpenAI in Talks for $6.5 Billion Funding, Valuation Soars to $150 Billion

(Source-coingape.com) OpenAI is reportedly in discussions to raise approximately $6.5 billion in a funding round that could value the company…